![](/img/cover-not-exists.png)
Bleeding, mortality, and antiplatelet therapy: Results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial
Jeffrey S. Berger, Deepak L. Bhatt, P. Gabriel Steg, Steven R. Steinhubl, Gilles Montalescot, Mingyuan Shao, Werner Hacke, Keith A. Fox, Peter B. Berger, Eric J. Topol, A. Michael LincoffVolume:
162
Year:
2011
Language:
english
Pages:
1051
DOI:
10.1016/j.ahj.2011.04.015
File:
PDF, 327 KB
english, 2011